Elissa S. Cote - 23 Jun 2025 Form 3 Insider Report for Vistagen Therapeutics, Inc. (VTGN)

Role
Chief Corp Development Officer
Signature
/s/ Elissa S. Cote
Issuer symbol
VTGN
Transactions as of
23 Jun 2025
Net transactions value
$0
Form type
3
Filing time
25 Jun 2025, 17:15:54 UTC
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Cote Elissa S. Chief Corp Development Officer C/O VISTAGEN THERAPEUTICS, INC., 343 ALLERTON AVENUE, SOUTH SAN FRANCISCO /s/ Elissa S. Cote 25 Jun 2025 0002069951

No securities are beneficially owned.